4D Molecular Therapeutics Inc

FDMT

David H. Kirn is an American entrepreneur-innovator, physician-scientist, CEO and professor. He is co-founder and CEO of 4D Molecular Therapeutics (4DMT), a biotechnology company designing and developing adeno-associated virus gene therapy vectors.Kirn is the co-founder and board member of the Life …

Insider trades and stock quote 2023-2025

221.51.5110.50.500Jun '23Jun '23Aug '23Aug '23Oct '23Oct '23Dec '23Dec '23Feb '24Feb '24Apr '24Apr '24Jun '24Jun '24Aug '24Aug '24Oct '24Oct '24Dec '24Dec '24Feb '25Feb '25Apr '25Apr '25Sell (2)Sell (2)Sell (2)Sell (2)SellSellSellSellSellSellSellSellSellSellSellSellSellSellSellSellSellSellSellSell

All insider trades at 4D Molecular Therapeutics Inc

Subscribe RSS
DateTypeInsiderPositionØ-PriceVolume
9/16/2024 SellBizily, Scott Chief Legal Officer $16.3 $8,165
8/19/2024 SellBizily, Scott Chief Legal Officer $15.0 $7,500
7/16/2024 SellBizily, Scott Chief Legal Officer $27.1 $47,443
7/11/2024 SellBizily, Scott Chief Legal Officer $25.0 $49,900
7/10/2024 SellKirn, David Chief Executive Officer $22.5 $290,598
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)

Free Updates via Email

Get a summary with the most interesting insider trades of the last weeks.
See data protection agreement.